在这里帮新同学简单提炼下
1、该公司成立时间久(40+年),临床应用以及积累的数据多,科研投入大;
在基因领域,积累的样板数据,很多时候是壁垒门槛;
2、公司是澳大利亚本土与美股双上市,澳大利亚本土业绩在过去...查看全文
基因技术ADR(GENE)2023-02-01 20:33
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-003240 Act: 34 Size: 59 KB 网页链接查看全文
基因技术ADR(GENE)04-19 18:15
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-015267 Act: 34 Size: 44 KB 网页链接查看全文
基因技术ADR(GENE)04-11 20:05
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-014275 Act: 34 Size: 51 KB 网页链接查看全文
基因技术ADR(GENE)04-17 18:15
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-014970 Act: 34 Size: 41 KB 网页链接查看全文
基因技术ADR(GENE)04-08 20:05
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-013414 Act: 34 Size: 40 KB 网页链接查看全文
基因技术ADR(GENE)03-22 20:05
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010906 Act: 34 Size: 77 KB 网页链接查看全文
Tonymok2015-08-07 08:18
笔者 增加一个投资板块,根据我国老龄化进程。$基因技术ADR(GENE)$ DNA生物工程将是将来的大方向。医疗设备与基因工程板块。基因工程是建立在医疗设备升级下的上下游覆盖产业链。查看全文
-大奇葩2015-05-07 01:59
做这类股不需要太多分析,你只要想着我买入完还有比我贪婪的人为我接盘和拉高股价,还有我得跑得快不能成为接盘侠,这样就成功了$PLASMATECH BIOPHARMACEUTICAL(PTBI)$ $VOLTARI CORP(VLTC)$ $基因技术ADR(GENE)$ 「前提是你贪婪的足够早,跑得比别人快,不然你就是接盘者」查看全文
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-015267 Act: 34 Size: 44 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-014970 Act: 34 Size: 41 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-014275 Act: 34 Size: 51 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-013414 Act: 34 Size: 40 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011237 Act: 34 Size: 37 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011076 Act: 34 Size: 516 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010906 Act: 34 Size: 77 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010730 Act: 34 Size: 852 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-009145 Act: 34 Size: 63 KB 网页链接
$基因技术ADR(GENE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-007771 Act: 34 Size: 5 MB 网页链接